10‐(4‐Fluorophenyl)‐3,3,6,6,9‐pentamethyl‐3,4,6,7,9,10‐hexahydroacridine‐1,8(2H,5H)‐dione and 10‐(4‐fluorophenyl)‐3,3,6,6‐tetramethyl‐9‐­propyl‐3,4,6,7,9,10‐hexahydroacridine‐1,8(2H,5H)‐dione

10‐(4‐Fluoro­phenyl)‐3,3,6,6,9‐penta­methyl‐3,4,6,7,9,10‐hexa­hydro­acridine‐1,8(2H,5H)‐dione, C₂₄H₂₈FNO₂, (I), crystallizes with two crystallographically independent mol­ecules (which differ slightly in conformation), while 10‐(4‐fluoro­phenyl)‐9‐propyl‐3,3,6,6‐tetra­methyl‐3,4,6,7,9,10‐hexa­hydro­acridine‐1,8(2H,5H)‐dione, C₂₆H₃₂FNO₂, (II), crystallizes with one mol­ecule per asymmetric unit. In both structures, the central ring in the acridine moiety is in a sofa conformation, while the outer rings adopt intermediate half‐chair/sofa conformations. The central pyridine ring is orthogonal to the substituted phenyl ring. In both structures, the packing of the crystal is stabilized by C—H?O intermolecular hydrogen bonds.     

Two optically active iso­quinoline derivatives

In the two title optically active tetra­hydro­iso­quinoline derivatives, namely 3‐hydroxy­methyl‐4‐phenyl‐1,2,3,4‐tetra­hydro­isoquinolin‐2‐ium bromide methanol hemisolvate, C₁₆H₁₈NO⁺·Br^?·0.5CH₃OH, (IIb), and 2‐formyl‐3‐hydroxy­methyl‐4‐phenyl‐1,2,3,4‐tetra­hydro­iso­quinoline, C₁₇H₁₇NO₂, (III), the absolute configurations have been confirmed as 3R,4R by structure refinement using Bijvoet‐pair reflections. The hydroxy­methyl and phenyl groups in (IIb) are oriented in equatorial and pseudo‐equatorial positions, respectively, whereas in (III), the corresponding groups are in axial and pseudo‐axial positions, respectively; the hydroxy­methyl and phenyl groups are trans with respect to one another in both structures. The heterocyclic rings in (IIb) and (III) adopt envelope conformations inverted with respect to each other. In both structures, the mol­ecules are linked through hydrogen bonds.     

2‐Nitroso‐1,3‐diphenyl‐1,2,3,4‐tetrahydrobenzo[b][1,6]naphthyridine

The title compound, C₂₄H₁₉N₃O, crystallizes in the centrosymmetric space group P2₁/a with one mol­ecule in the asymmetric unit. The tetra­hydro­pyridine ring has a boat conformation. The dihedral angle between the fused pyridine rings is 16.2 (1)°. The equatorial and axial orientations of the two phenyl groups with respect to the tetra­hydro­pyridine ring are confirmed. The nitroso group is coplanar with the attached C—N—C group. The interplanar angle formed between the fused tetra­hydro­pyridine and benzene planes is 13.4 (1)°. The crystal packing is stabilized by an intermolecular C—H⃛O hydrogen bond, which forms a C(9) graph‐set chain running along the [001] direction.     

Supramolecular hydrogen‐bonded hexamers in two 5‐aryl‐3‐methyl‐1‐phenyl‐1,6,7,8‐tetra­hydro­pyrazolo­[3,4‐b][1,4]­diazepines

In both title compounds, i.e. 3‐methyl‐1,5‐di­phenyl‐1,6,7,8‐tetra­hydro­pyrazolo­[3,4‐b][1,4]­diazepine, C₁₉H₁₈N₄, (I), and 5‐(4‐chloro­phenyl)‐3‐methyl‐1‐phenyl‐1,6,7,8‐tetra­hydro­pyra­zolo­[3,4‐b][1,4]­diazepine, C₁₉H₁₇ClN₄, (II), an N—H?N hydrogen bond links six mol­ecules to form an R(30) ring. Compound (I) crystallizes in the R space group and (II) crystallizes in P with three mol­ecules in the asymmetric unit. The mol­ecule of (I) contains a disordered seven‐membered ring.     

Two stereoisomers of the rat toxicant norbormide

The structures of two diastereoisomers of norbormide {systematic name: 5‐[hydroxy­(phenyl)(2‐pyridyl)­methyl]‐8‐[phenyl(2‐pyridyl)­methyl­ene]‐3a,4,7,7a‐tetra­hydro‐4,7‐methano‐1H‐iso­indole‐1,3(2H)‐dione}, viz. the unsolvated mol­ecule, C₃₃H₂₅N₃O₃, and the ethyl acetate hemisolvate, C₃₃H₂₅N₃O₃·0.5C₄H₈O₂, have been determined unambiguously. They differ in the relative stereochemistry about the exocyclic double bond and the relative conformations of the aryl rings. Each compound exhibits both intra‐ and intermolecular hydrogen bonding.     

Supramolecular structures of 5‐[3‐(4‐methyl­phenyl)‐ and 5‐[3‐(4‐chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione

2,2‐Di­methyl‐5‐[3‐(4‐methyl­phenyl)‐2‐propenyl­idene]‐1,3‐di­ox­ane‐4,6‐dione, C₁₆H₁₆O₄, crystallizes in the triclinic space group , with two mol­ecules in the asymmetric unit. These mol­ecules and a centrosymmetrically related pair, linked together by weak C—H?O hydrogen bonds, form a tetramer. 5‐[3‐(4‐Chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione, C₁₅H₁₃ClO₄, also crystallizes in the triclinic space group , with one mol­ecule in the asymmetric unit. Centrosymmetrically related mol­ecules are linked together by weak C—H?O hydrogen bonds to form dimers which are further linked by yet another pair of centrosymmetrically related C—H?O hydrogen bonds to form a tube which runs parallel to the a axis.     

Two carbamoyl‐substituted di­hydro­pyrimidines: potential mimics of di­hydro­pyridine calcium channel blockers

The structures of two conformationally similar 1,4‐di­hydro­pyrimidines with a novel carbamoyl substitution, viz. 6‐methyl‐5‐(N‐methyl­carbamoyl)‐4‐phenyl‐1,2,3,4‐tetrahydro­py­rimidine‐2‐thione monohydrate, C₁₃H₁₅N₃OS·H₂O, (I), and 4‐(4‐chloro­phenyl)‐6‐methyl‐5‐(N‐methyl­carbamoyl)‐1,2,3,4‐tetra­hydro­pyrimidine‐2‐thione monohydrate, C₁₃H₁₄ClN₃OS·H₂O, (II), exhibit the structural features of 1,4‐di­hydro­pyridine calcium channel blockers. In both structures, the pyrimidine ring adopts a flattened boat conformation and the carbamoyl side chain is in an extended conformation with an anticlinal orientation. The phenyl ring occupies a pseudo‐axial position with respect to the pyrimidine ring in these structures. Both compounds crystallize with one mol­ecule of water, which participates in a two‐dimensional hydrogen‐bonding network. The mol­ecules are linked into dimers by N—H·S hydrogen bonds in both structures.     

The antiestrogen [2‐(4‐benzyl­phenoxy)­ethyl]­diethyl­ammonium chloride

The crystal structure of the title compound, C₁₉H₂₆NO⁺·Cl^? (common name: N,N‐diethyl‐2‐[(4‐phenyl­methyl)phenoxy]‐ethan­amine hydro­chloride), contains one mol­ecule in the asymmetric unit. The planes through the two phenyl rings are roughly perpendicular. Protonation occurs at the N atom, to which the Cl^? ion is linked via an N—H?Cl hydrogen bond. The mol­ecule adopts an eclipsed rather than extended conformation.     

(1S,2R,2′S)‐ and (1S,2S,2′S)‐1‐phenyl‐2‐phenyl­thio‐2‐(tetra­hydro­pyran‐2′‐yl­thio)­ethanol diastereoisomers at 193 K

In the synthesis of 1‐phenyl‐2‐phenyl­thio‐2‐(tetra­hydro­pyran‐2‐yl­thio)­ethanol, C₁₉H₂₂O₂S₂, four diastereoisomers are formed. Two non‐centrosymmetric enantiomeric forms which crystallize in space groups P2₁2₁2₁ and Pna2₁ are presented. The former has an intramolecular hydrogen bond between the hydroxyl group and the O atom of the tetra­hydro­pyran ring. In the latter isomer, the hydroxyl group forms an intermolecular hydrogen bond to the O atom of the tetra­hydro­pyran­yl group of a neighbouring mol­ecule, joining the mol­ecules into chains in the c‐axis direction; the O?O distances are 2.962 (4) and 2.764 (3) Å, respectively. The tetra­hydro­pyran rings are in chair conformations in both isomers and the S side chain has an equatorial orientation in the former, but an axial orientation in the latter mol­ecule.     

The potent anticancer compound ecteinascidin‐743 (ET‐743) as its 2‐propanol disolvate

Single crystals of the title compound, C₃₉H₄₃N₃O₁₁S·2C₃H₈O, have been obtained from 2‐propanol/water solutions. ET‐743 belongs to the group of ecteinascidins (ETs), which is a family of novel marine tetra­hydro­iso­quinoline derivatives characterized by a monobridged pentacyclic skeleton. Three large princi­pal planar groups are observed in the three‐dimensional structure of the ET‐743 mol­ecule, corresponding to three aromatic units which are nearly perpendicular to each other. In the crystal, the methoxy group on the large fused ring system adopts an anti conformation with respect to the S atom, thus presenting the same conformation as that found in solution.     

3‐Amino‐4′‐methyl­‐5‐ethylbi­phenyl‐2,4‐dicarbo­nitrile and 3‐amino‐4′‐(N,N‐diethyl­amino)‐5‐ethyl­bi­phenyl‐2,4‐dicarbo­nitrile

In the title compounds, C₁₇H₁₅N₃ and C₂₀H₂₂N₄, the methyl derivative crystallizes with two mol­ecules in the asymmetric unit, while the N,N‐diethyl­amino derivative crystallizes with one mol­ecule per asymmetric unit. The bi­phenyl twist angle for both mol­ecular structures is approximately 45°. The molecular packing is stabilized by N—H?N hydrogen bonds.     

Cyclo(l‐leucyl‐α,β‐dehydro­phenyl­alanine): the first diketopiperazine containing an α,β‐dehydro­phenyl­alanine residue

The title compound (systematic name: 3‐benzyl­idene‐6‐iso­butyl­piperazine‐2,5‐dione), C₁₅H₁₈N₂O₂, an α,β‐dehydro­phenyl­alanine containing diketopiperazine, crystallizes in the space group P1 with two mol­ecules in the asymmetric unit arranged antiparallel to one another. The α,β‐dehydro­phenyl­alanine (ΔPhe) residue in this cyclic peptide retains its planarity but deviates from the standard conformations observed in its linear analogues. Each type of mol­ecule forms a linear chain with mol­ecules of the same type via pairwise N—H⋯O hydrogen bonds, while weaker C—H⋯O inter­actions link the chains together to form a three‐dimensional network.     

Absolute configuration of N-[(–)-2-(7-methoxy-1,2,3,4-tetra­hydro­-1-naphthyl)­ethyl]­cyclo­propyl­carbox­amide,a highly potent and selective melatonin analogue

The title compound, C₁₇H₂₃NO₂, a tetra­hydro­naphthalenic analogue of melatonin, crystallizes in the monoclinic space group P2₁ with one mol­ecule in the asymmetric unit. The crystal structure has been determined by X-ray analysis at room temperature. The absolute configuration of this compound was determined unambiguously as R at the chiral naphthalene C-1 position.     

Cocrystals of diastereoisomers of 1,4‐dihydro­pyridine derivatives

A mixture of the RR/SS and RS/SR diastereoisomeric pairs of methyl 4‐(2,4‐dichloro­phen­yl)‐2,7‐dimethyl‐5‐oxo‐1,4,5,6,7,8‐hexa­hydro­quinoline‐3‐carboxyl­ate, C₁₉H₁₉Cl₂NO₃, forms cocrystals in which there is one unique mol­ecule in the asymmetric unit, but the mol­ecule displays disorder in the region of the 7‐position of the quinoline ring system as a result of the random occurrence of the diastereoisomers at the same crystallographic site. A similar arrangement exists in the monohydrate cocrystals that form from a mixture of the RR/SS and RS/SR diastereoisomeric pairs of methyl 4‐(2,4‐dichloro­phen­yl)‐2‐methyl‐7‐phenyl‐5‐oxo‐1,4,5,6,7,8‐hexa­hydro­quinoline‐3‐carboxyl­ate monohydrate, C₂₄H₂₁Cl₂NO₃·H₂O. These compounds belong to a class of 1,4‐dihydro­pyridines whose members have calcium modulatory properties. The 1,4‐dihydro­pyridine rings have the usual shallow boat conformation. In each structure, the 2,4‐dichloro­phenyl ring is oriented such that the 2‐chloro substituent is in a synperi­planar orientation with respect to the 1,4‐dihydro­pyridine ring plane. In each crystal structure, the mol­ecules are linked into chains by N—H⋯O hydrogen‐bonding inter­actions.     

rac‐(Z)‐Ethyl 2‐bromo‐2‐[(3R,5R)‐3‐bromo‐5‐methyl­tetra­hydro­furan‐2‐yl­idene]acetate

In the title compound, C₉H₁₂Br₂O₃, a (tetra­hydro­furan‐2‐yl­idene)acetate, the double bond has the Z form. In the tetra­hydro­furan group, the relative configuration of the Br atom in the 3‐position and the methyl group in the 5‐position is anti. The compound crystallizes with two independent mol­ecules per asymmetric unit and, in the crystal structure, the individual mol­ecules are linked to their symmetry‐equivalent mol­ecules by C—H⋯O hydrogen bonds, so forming centrosymmetric hydrogen‐bonded dimers.     

The titanium–thiolate complex [Li(C4H8O)4][Ti2(SC6H5)9]

In the title compound, tetrakis­(tetra­hydro­furan)­lithium(I) tri‐μ‐phenyl­thiol­ato‐bis­[tris­(phenyl­thiol­ato)­titanate(IV)], [Li(C₄H₈O)₄][Ti₂(C₆H₅S)₉], (I), the central structural motif of the [Ti₂(SC₆H₅)₉]^? anion features a face‐sharing bi‐octa­hedron. The charge is balanced with a [Li(C₄H₈O)₄]⁺ cation. The asymmetric unit contains Ti, Li and a heavily disordered tetra­hydro­furan mol­ecule on a threefold axis, and two terminal and a bridging thio­phenolate moiety and a slightly disordered tetra­hydro­furan mol­ecule on general positions.     

A cis‐stilbene derivative

The title compound, 4′‐methoxy‐α,2,3′,4‐tetra­nitro­stilbene, C₁₅H₁₀N₄O₉, crystallizes in the centrosymmetric space group P2₁/c with one mol­ecule in the asymmetric unit. The phenyl rings are inclined to one another and form a dihedral angle of 57.4 (1)°. The size of this angle is a result of intermolecular C—H⃛O interactions involving the phenyl H atoms. The torsion angle between the phenyl rings, −7.5 (3)°, indicates a cis geometry between them. The methoxy group is almost coplanar with the phenyl ring, and the nitro groups are twisted with respect to the phenyl rings because of the short H⃛O contacts. The crystal packing is stabilized by C—H⃛O hydrogen bonds, and the intermolecular hydrogen bonds form a C(12) graph‐set chain running along the [010] direction.     

A di­deoxy­dide­hydro­nucleoside derivative

We have synthesized a di­deoxy­dide­hydro­nucleoside derivative, 2(S)‐acetoxymethyl‐4‐[4‐amino‐2‐oxopyrimidin‐1(2H)‐yl]‐2,5‐di­hydro­furan, C₁₁H₁₃N₃O₄, which is an analogue of the potently anti‐HIV active compound, di­deoxy‐dide­hydro­cytidine (d4C). The target compound crystallizes with two mol­ecules in the asymmetric unit that differ primarily in the orientation of the C6′‐acetyl group. One mol­ecule has an extended conformation and the orientation of the acetyl group in the second mol­ecule gives an unusual hooked‐shaped conformation. The two conformers form A–B dimers via N—H?N hydrogen bonds. The dimers link via N—H?O hydrogen bonds to form chains parallel to the b cell axis.     

l‐Phenyl­alanyl‐l‐tryptophan 0.75‐hydrate

The title compound, C₂₀H₂₁N₃O₃·0.75H₂O, crystallizes as exceedingly thin fibers. The crystal packing arrangement is related to those of other hydro­phobic dipeptides with phenyl­alanine residues, but the structure has pseudo‐tetra­gonal symmetry in an ortho­rhom­bic space group with four peptide mol­ecules and three water mol­ecules in the asymmetric unit.     

An azo dye mol­ecule having a pyridine‐2,6‐dione backbone

The title azo dye, 2‐(2‐methoxy­ethoxy)ethyl 4‐[(5‐cyano‐1‐ethyl‐4‐methyl‐2,6‐dioxo‐1,2,3,6‐tetra­hydro­pyridin‐3‐ylidene)hydrazino]benzoate, C₂₁H₂₄N₄O₆, with a 1‐ethyl‐5‐cyano‐2‐hydr­oxy‐4‐methyl‐6‐pyridone component, crystallizes in the hydrazone form. Hydrogen bonding mediates the formation of four‐mol­ecule aggregates, which are further grouped into an extended structure by π–π stacking inter­actions between the aromatic rings of adjacent mol­ecules, with a centroid–centroid separation of 3.697 (2) Å.